On-demand treatment in persons with severe haemophilia (Q38222575)

31 August 2017

title

On-demand treatment in persons with severe haemophilia (English)

1 reference

31 August 2017

0 references

Katarina Steen Carlsson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957106 AND SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Sonata Saulyte Trakymiene

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957106 AND SRC:MED&resulttype=core&format=json

9 June 2020

publication date

1 August 2014

1 reference

European journal of haematology. Supplementum

31 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957106 AND SRC:MED&resulttype=core&format=json

9 June 2020

volume

76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957106 AND SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

39-47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24957106 AND SRC:MED&resulttype=core&format=json

Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.

9 June 2020

cites work

1 reference

Prophylaxis in haemophilia

21 January 2018

1 reference

Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome.

21 January 2018

1 reference

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia

21 January 2018

1 reference

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).

21 January 2018

1 reference

Musculoskeletal complications of haemophilia: the joint

21 January 2018

1 reference

Methods of haemophilia care delivery: regular prophylaxis versus episodic treatment

21 January 2018

1 reference

Cost-effectiveness of prophylaxis against on-demand treatment in boys with severe hemophilia A in Iran

21 January 2018

1 reference

Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study

21 January 2018

1 reference

Effects of secondary prophylaxis started in adolescent and adult haemophiliacs

21 January 2018

1 reference

A comparison between prophylaxis and on demand treatment for severe haemophilia

21 January 2018

1 reference

Cost effectiveness of haemophilia treatment: a cross-national assessment

21 January 2018

1 reference

Comparative effectiveness of plasma-derived and recombinant FVIII concentrates in the on-demand and prophylactic treatment of patients with haemophilia A.

21 January 2018

1 reference

Health status and health-related quality of life of children with haemophilia from six West European countries

21 January 2018

1 reference

On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome

21 January 2018

1 reference

Comparing outcomes of different treatment regimens for severe haemophilia

21 January 2018

1 reference

Results of an orthopaedic survey in young patients with severe haemophilia in Spain

21 January 2018

1 reference

Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients

21 January 2018

1 reference

Clinical outcomes and resource utilization associated with haemophilia care in Europe

21 January 2018

1 reference

The orthopaedic status of severe haemophiliacs in Spain

21 January 2018

1 reference

Resource utilisation in haemophiliacs treated in Europe: results from the European Study on Socioeconomic Aspects of Haemophilia Care. The European Socioeconomic Study Group

21 January 2018

1 reference

Prophylactic therapy for hemophilia in a developing country, Turkey

21 January 2018

1 reference

Episodic versus prophylactic infusions for hemophilia A: a cost-effectiveness analysis

21 January 2018

1 reference

Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials

21 January 2018

1 reference

Newer approaches to the study of hemophilia and hemophilioid states

21 January 2018

1 reference

Treatment on demand--in vivo dose finding studies

21 January 2018

1 reference

Double-blind controlled trial of three dosage regimens in treatment of haemarthroses in haemophilia A

21 January 2018

1 reference

A double-blind controlled trial of two dose levels of factor VIII in the treatment of high risk haemarthroses in haemophilia A.

21 January 2018

1 reference

Guidelines on treatment of haemophilia in Sweden

21 January 2018

1 reference

Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy

21 January 2018

1 reference

21 January 2018

Modern haemophilia care

1 reference

Wound healing in haemophilia--breaking the vicious cycle.

21 January 2018

1 reference

Exploration of the pathogenesis of haemophilic joint arthropathy: understanding implications for optimal clinical management

21 January 2018

1 reference

Hemophilia home treatment. Economic analysis and implications for health policy

21 January 2018

1 reference

Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy

21 January 2018

1 reference